The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits
about
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III)Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors
P2860
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The prolyl 4-hydroxylase inhib ...... cognitive behavioral deficits
@en
type
label
The prolyl 4-hydroxylase inhib ...... cognitive behavioral deficits
@en
prefLabel
The prolyl 4-hydroxylase inhib ...... cognitive behavioral deficits
@en
P2093
P2860
P1433
P1476
The prolyl 4-hydroxylase inhib ...... cognitive behavioral deficits
@en
P2093
Carrie Poon
Daniel M Rosenbaum
Frank C Barone
Jian Zhuang
John Lepore
Katrina Rivera
Robert N Willette
P2860
P304
P356
10.1371/JOURNAL.PONE.0184049
P407
P50
P577
2017-09-07T00:00:00Z